Stockreport

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that the Phase 1 trial of NMRA-266 has been placed on clinica [Read more]